Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...

Bayer is pressing ahead with a phase ... with prior ischaemic stroke or high-risk TIA, on top of aspirin and antiplatelet therapy. The drug numerically reduced the risk of clinical ischaemic ...

The San Francisco 49ers beat the Denver Broncos 55-10 in the biggest blowout in Super Bowl history in the seventh ...

In a bold move to restore $540 million in cost savings, Bayer ... of Nubeqa - a drug that’s already generated over $1 billion USD. The company offers a complex portfolio, from aspirin and ...

.Semaglutide: Novo Nordisk Semaglutide is a long-acting oral GLP-1 analogue being developed and investigated by Novo Nordisk. The drug is currently being evaluated under Phase III clinical trial for ...

So I was intrigued to read last year about the radical plan to attack bureaucracy at German pharma company Bayer. The company, which invented aspirin ... Anderson cited drug teams radically ...

acetylsalicylic acid tablet in preventing or decreasing any gastrointestinal intolerance to aspirin ... (Bayer) for this study were kindly furnished by the National Brands Division of Sterling ...

Partially offsetting this are declines in cardiovascular drug Xarelto ... margins. Bayer’s healthcare segment also includes a consumer healthcare business with leading brands Aspirin and Aleve.

Medications are prescribed on a symptomatic basis—aspirin, for instance ... Joining Renova against CHF is Bayer subsidiary Asklepios BioPharmaceutical, or AskBio. The North Carolina–based biotech is ...